Niacinamide for Skin: 5 Facts From Official Sources

Niacinamide is a form of vitamin B3 used in many moisturizers and serums, and a 2021 peer-reviewed review of clinical trials found that topical nicotinamide reduces the progression of skin aging and hyperpigmentation while being well tolerated by the skin. Here are five facts about niacinamide drawn from the National Institutes of Health and the FDA, so you can read a label with context instead of hype.

In this guide: - What niacinamide is and where the name comes from - What clinical trials actually tested, at which concentrations - What the ingredient is not: a drug, and not FDA pre-approved - How to approach niacinamide products safely - Reading a niacinamide label: a quick checklist

Fact 1: It is a form of vitamin B3

Niacinamide is also called nicotinamide. The National Institutes of Health Office of Dietary Supplements states that niacin, also known as vitamin B3, is one of the water-soluble B vitamins, and that niacin is the generic name covering nicotinic acid, nicotinamide (niacinamide), and related derivatives. In skincare, niacinamide is used as a cosmetic ingredient, which means it is not sold as a drug and does not need to prove it treats any condition.

That distinction matters for how you read a label. A product that lists niacinamide is a cosmetic; statements about treating disease would move it into drug territory, which is why responsible brands keep their language to appearance.

Fact 2: A 2021 review summarized the clinical-trial evidence

A peer-reviewed review published in 2021 in the journal Antioxidants surveyed the clinical evidence on nicotinamide in dermatology. Its conclusion, as indexed on PubMed, is that topical treatment with nicotinamide, alone or combined with other active ingredients, reduces the progression of skin aging and hyperpigmentation in clinical trials, and that topically applied nicotinamide is well tolerated by the skin.

A 2021 review is recent enough to reflect the current evidence base, and a review carries more weight than any single small trial because it weighs multiple studies together. Treat it as the best available summary rather than a final verdict: future trials can always refine the picture.

Finding	Concentration tested	Source
Skin aging and hyperpigmentation progression reduced in trials	2% and 5% moisturizers	2021 peer-reviewed review (PMID 34439563)
Split-face comparison of two concentrations	5% vs. 2%, twice daily	8-week trial cited in the review
Skin barrier improvement in rosacea-prone subjects	2% moisturizer	Trial cited in the review

What the table shows: the tested range sits in the low single digits, with 2% and 5% moisturizers as the concentrations the trials actually used. When a product lists niacinamide high on its ingredient list, that is the range the published research supports. A product with only a trace amount is not what these trials tested.

Fact 3: The evidence is narrow, not a cure claim

The trials behind the review looked at specific outcomes: the appearance of skin aging, hyperpigmentation, and skin barrier function in defined study populations over weeks. A separate trial cited in the review found that a facial moisturizer containing 2% nicotinamide improved skin barriers in patients with rosacea.

These are narrow findings. They do not mean niacinamide treats rosacea, acne, or any skin condition, and no cosmetic ingredient can carry a disease-treatment claim. They describe what researchers observed under controlled conditions, which is useful context but not a promise about any single product.

Fact 4: Cosmetics are not FDA pre-approved

The FDA states that cosmetic products and ingredients are not subject to FDA premarket approval, with the exception of color additives. Companies that market cosmetics are legally responsible for the safety of their products, but there is no FDA clearance stamp on a moisturizer the way there is on a drug.

This is not a warning about niacinamide specifically. It is context for every cosmetic ingredient: the safety record comes from published research, industry data, and post-market experience. The FDA can take action against products on the market that violate the law, but it does not review them before sale.

Fact 5: Start gently and watch your skin

The review describes topical nicotinamide as well tolerated, but any active ingredient can irritate some people, especially on sensitive or compromised skin. If you are trying a niacinamide product for the first time, apply it to a small area first and watch for redness or stinging over several days. Stop using the product if irritation appears, and introduce only one new product at a time so a reaction has a single suspect.

If you have a diagnosed skin condition, are pregnant, or take prescription skin medication, talk to a dermatologist before adding a new active ingredient to your routine. A professional can tell you whether niacinamide fits with the treatments you already use.

Reading a niacinamide label: a quick checklist

Find niacinamide, also labeled nicotinamide, on the ingredient list. FDA labeling rules require cosmetic ingredients to appear in descending order of predominance, so higher placement generally means higher concentration.
Compare against the trial range. The published trials used 2% and 5% moisturizers, so a product that states its percentage lets you match that range directly. No percentage on the label means you cannot make that comparison.
Introduce one new active at a time. If your skin reacts, a single change makes the cause obvious.
Keep expectations cosmetic. The trials measured appearance outcomes over weeks, not overnight transformation, and no cosmetic treats disease.